ListarCIENCIAS EXPERIMENTALES por tema "Alzheimer’s disease"
Mostrando ítems 1-7 de 7
-
Cannabinoid CB2 Receptors Modulate Microglia Function and Amyloid Dynamics in a Mouse Model of Alzheimer’s Disease. Ruiz de Martín Esteban, Samuel; Benito Cuesta, Irene; Terradillos, Itziar; Martínez Relimpio, Ana María; Arnanz, M. Andrea; Ruiz-Pérez, Gonzalo; Korn, Claudia; Raposo, Catarina; Sarott, Roman C.; Westphal, Matthias V.; Elezgarai, Izaskun; Carreira, Erick M.; Hillard, Cecilia J.; Grether, Uwe; Grandes, Pedro; Grande Rodríguez, Mª Teresa; Romero, Julián (Frontiers in Pharmacology, 2022)
-
Cannabinoid receptor CB2 ablation protects against TAU induced neurodegeneration. Galán Ganga, M.; Rodríguez Cueto, C.; Merchán Rubira, J.; Hernández, F.; Ávila, J.; Posada Ayala, María; Lanciego, J.L.; Luengo, E.; López, M. G.; Rábano, A.; Fernández Ruiz, J.; Lastres Becker, I. (Acta Neuropathological Communications, 2021)
-
Mitophagy Failure in APP and Tau Overexpression Model of Alzheimer’s Disease. Martín Maestro, Patricia; Gargini, Ricardo; García, Esther; Simón, Diana; Ávila, Jesús; García Escudero, Vega (Journal of Alzheimer's Disease, 2019)
-
Olfactory ensheathing cell-conditioned medium reverts 3 Ab25–35-induced oxidative damage in SH-SY5Y cells 4 by modulating the mitochondria-mediated apoptotic pathway. Fu, Qing-Qing; Sierra Isturiz, Javier; Cheng, Jian-Zhang; Moreno Flores, María Teresa; You, Hua; Hua-Rong, Yu (Cellular and Molecular Neurobiology, 2016)
-
RNA methyltransferase NSun2 deficiency promotes neurodegeneration through epitranscriptomic regulation of tau phosphorylation. Kim, Yoon A.; Siddiqui, Tohid; Blaze, Jennifer; Ilyas Cosacak, Mehmet; Winters, Tristan; Kumar, Atul; Tein, Ellen; Sproul, Andrew A.; Teich, Andrew F.; Bartolini, Francesca; Akbarian, Schahram; Kizil, Caghan; Hargus, Gunnar; Santa-María, Ismael (Acta Neuropathologica, 2022)
-
Tridimensional Structural Analysis of Tau Isoforms Generated by Intronic Retention. Domene-Serrano, Indalo; Cuadros, Raquel; Hernández, Félix; Ávila, Jesús; Santa-María, Ismael (Journal of Alzheimer's Disease Reports, 2023)